BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 16706806)

  • 81. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
    Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
    Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Proliferative drive and liver carcinogenesis: too much of a good thing?
    Teoh NC
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
    Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
    Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis.
    Niketeghad F; Decker HJ; Caselmann WH; Lund P; Geissler F; Dienes HP; Schirmacher P
    Br J Cancer; 2001 Sep; 85(5):697-704. PubMed ID: 11531255
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
    Park SJ; Jeong SY; Kim HJ
    Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
    [TBL] [Abstract][Full Text] [Related]  

  • 86. DNA methylation in hepatocellular carcinoma.
    Tischoff I; Tannapfe A
    World J Gastroenterol; 2008 Mar; 14(11):1741-8. PubMed ID: 18350605
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epigenetic alterations in gastric carcinogenesis.
    Choi IS; Wu TT
    Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.
    Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10060-5. PubMed ID: 12110732
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma.
    Nishida N; Kudo M; Nishimura T; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Yokomichi N; Nagasaka T; Goel A
    PLoS One; 2013; 8(9):e72312. PubMed ID: 24023736
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter.
    Min JY; Lim SO; Jung G
    FEBS Lett; 2010 Jun; 584(11):2427-32. PubMed ID: 20416298
    [TBL] [Abstract][Full Text] [Related]  

  • 91. DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.
    Arai E; Kanai Y
    Epigenomics; 2010 Jun; 2(3):467-81. PubMed ID: 22121905
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Epigenetic methylation of TIMP-3 may play a role in HBV-associated hepatocellular carcinoma.
    Lai HJ; Lo SJ
    Chang Gung Med J; 2005 Jul; 28(7):453-5. PubMed ID: 16231528
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cellular and molecular mechanisms of hepatocarcinogenesis.
    Rogler CE; Chisari FV
    Semin Liver Dis; 1992 Aug; 12(3):265-78. PubMed ID: 1439879
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.
    Feo F; Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi D
    Crit Rev Oncog; 2000; 11(1):19-62. PubMed ID: 10795626
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Integrated analysis of genetic and epigenetic alterations in cancer.
    Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y
    Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.
    Zhu Q; Gong L; Liu X; Wang J; Ren P; Zhang W; Yao L; Han X; Zhu S; Lan M; Li Y; Zhang W
    Diagn Pathol; 2015 Jun; 10():70. PubMed ID: 26076954
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The altered DNA methylation pattern and its implications in liver cancer.
    De Zhu J
    Cell Res; 2005 Apr; 15(4):272-80. PubMed ID: 15857582
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Frequent chromosomal instability but no microsatellite instability in hepatocellular carcinomas.
    Piao Z; Kim H; Malkhosyan S; Park C
    Int J Oncol; 2000 Sep; 17(3):507-12. PubMed ID: 10938391
    [TBL] [Abstract][Full Text] [Related]  

  • 99. DNA methylation and environmental exposures in human hepatocellular carcinoma.
    Shen L; Ahuja N; Shen Y; Habib NA; Toyota M; Rashid A; Issa JP
    J Natl Cancer Inst; 2002 May; 94(10):755-61. PubMed ID: 12011226
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Interplay of genetic and epigenetic alterations in hepatocellular carcinoma.
    Lee SM; Kim-Ha J; Choi WY; Lee J; Kim D; Lee J; Choi E; Kim YJ
    Epigenomics; 2016 Jul; 8(7):993-1005. PubMed ID: 27411963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.